A team led by Weizmann scientists has discovered that the protein PSME4 is produced by cancer cells to stop the immune system from attacking the tumor. Reducing PSME4 levels should potentially render tumors more vulnerable to immunotherapy. https://www.jns.org/israeli-researchers-unmask-how-cancer-camouflages-itself/ https://wis-wander.weizmann.ac.il/life-sciences/dumpster-diving-cancer-tissue-uncovers-immune-evasion-mechanism https://www.nature.com/articles/s43018-023-00557-4

Researchers at Israel’s Technion Institute have engineered an RNA molecule that repairs a damaged ubiquitin-proteasome system – a possible cause of Alzheimer’s disease. A faulty ubiquitin system leads to the accumulation of toxic proteins and amyloid plaque in Alzheimer’s patients. … Continue reading →

Opaganib, a novel, twice-daily, oral medication developed by Israel’s RedHill Biopharma (see here previously) delivered a statistically significant increase in survival time in a United States Army Medical Research Institute of Infectious Diseases (USAMRIID) in vivo Ebola virus study https://www.israel21c.org/drug-shows-promise-in-treating-often-fatal-ebola-disease/

Israel’s Belong.Life (see here previously) has launched a chatbot “Tara” – a conversational AI cancer clinical trial matching platform. It records cancer type, mutation, diagnosis, treatment history, and can even scan medical files. Belong.Life also has platforms for IBD, MS, … Continue reading →

A male striped hyena was certainly not a laughing hyena when it was caught in an illegal snare. Veterinarians at Israel’s Wildlife Hospital in Ramat Gan saved the animal’s life, treating its infected foot and dislocated toes.   They also made … Continue reading →